Polydex Pharmaceuticals Stock Last Dividend Paid
POLXFDelisted Stock | USD 1.99 0.00 0.00% |
Polydex Pharmaceuticals fundamentals help investors to digest information that contributes to Polydex Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Polydex Pink Sheet. The fundamental analysis module provides a way to measure Polydex Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Polydex Pharmaceuticals pink sheet.
Polydex |
Polydex Pharmaceuticals Company Last Dividend Paid Analysis
Polydex Pharmaceuticals' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
CompetitionBased on the recorded statements, Polydex Pharmaceuticals has a Last Dividend Paid of 0.0. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
All Next | Launch Module |
Polydex Fundamentals
Return On Equity | -0.18 | |||
Return On Asset | -0.0824 | |||
Profit Margin | (0.25) % | |||
Operating Margin | (0.22) % | |||
Current Valuation | 2.23 M | |||
Shares Outstanding | 3.43 M | |||
Number Of Shares Shorted | 11 | |||
Price To Earning | 12.33 X | |||
Price To Book | 0.42 X | |||
Price To Sales | 0.51 X | |||
Revenue | 4.05 M | |||
Gross Profit | 970.3 K | |||
EBITDA | (568.16 K) | |||
Cash And Equivalents | 870.3 K | |||
Cash Per Share | 0.25 X | |||
Total Debt | 301.49 K | |||
Debt To Equity | 0.05 % | |||
Current Ratio | 5.88 X | |||
Book Value Per Share | 1.44 X | |||
Cash Flow From Operations | (238.54 K) | |||
Short Ratio | 0.02 X | |||
Earnings Per Share | (0.13) X | |||
Number Of Employees | 21 | |||
Beta | 0.33 | |||
Market Capitalization | 2.23 M | |||
Total Asset | 6.56 M | |||
Retained Earnings | (19.53 M) | |||
Working Capital | 2.12 M | |||
Current Asset | 3.41 M | |||
Current Liabilities | 1.28 M | |||
Z Score | 1.4 |
About Polydex Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Polydex Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Polydex Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Polydex Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
SGC | Superior Uniform Group | |
VLN | Valens | |
GNFT | Genfit | |
GAIA | Gaia Inc | |
BLBD | Blue Bird Corp |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Polydex Pink Sheet
If you are still planning to invest in Polydex Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Polydex Pharmaceuticals' history and understand the potential risks before investing.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |